Interaction of C1q and the collectins with the potential receptors calreticulin (cC1qR/Collectin receptor) and megalin

Immunobiology

Volumn 199, Issue 2, 1998, Pages 208-224

  Sim, Robert B ^b   Moestrup, Søren K ^c   Stuart, Guy R ^c   Lynch, Nicholas J ^a   Lu, Jinhua ^c   Schwaeble, Wilhelm J ^a   Malhotra, Rajneesh ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; CELL SURFACE RECEPTOR; COMPLEMENT COMPONENT C1Q; COMPLEMENT RECEPTOR; PLASMA PROTEIN;

CELLULAR DISTRIBUTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

EID: 0031689432     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80028-4     Document Type: Article

References (77)

1. TENNER, A. J., and N. R. COOPER. 1981. Identification of types of cells in human peripheral blood that bind C1q. J. Immunol. 126: 1174.
2. HAMADA, A., and B. M. GREENE. 1987. C1q Enhancement of IgG-Dependent Eosinophil-Mediated Killing of Schistosomula in Vitro. J. Immunol. 138: 1240.
3. HAMADA, A., J. YOUNG, R. A. CHMIELEWSKI, and B. M. GREENE. 1988. C1q Enhancement of antibody-Dependent Granulocyte-Mediated Killing of Nonphagocytosable Targets in Vitro. J. Clin. Invest. 82: 945.
4. TENNER, A. J., and N. R. COOPER. 1982. Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component. J. Immunol. 128: 2547.
5. BOBACK, D. A., M. M. FRANK, and A. J. TENNER. 1988. C1q Acts Synergistically with Phorbol Dibutyrate to activate CR1-mediated Phagocytosis by Human Mononuclear Phagocytes. Eur. J. Immunol. 18: 2001.
6. RIMOLDI, M. T., A. J. TENNER, D. BOBACK, and K. A. JOINER. 1989. Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by trypanosoma cruzi trypomastigotes. J. Clin. Invest. 84: 1982.
7. SHINGU, M., K. YOSHIOKA, M. NOBUNAGA, and T. MOTOMATU. 1989. C1q Binding to human vascular smooth muscle cells mediates immune complex deposition and superoxide generation. Inflammation. 13: 561.
8. DAHA, M. R., A. M. M. MILTENBURG, P. S. HIEMSTRA, N. KLAR-MOHAMAD, L. A. VAN ES, and V. W. M. VAN HINSBERGH. 1987. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro. Eur. J. Immunol. 18: 783.
9. HABICHT, G., G. BECK, and B. GHEBREHIWET. 1987. C1q inhibits the expression of lymphoblastoid cell line Interleukin 1 (IL-1). J. Immunol. 138: 2593.
10. SUBA, E. A., and G. CSAKO. 1976. C1q (C1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules. J. Immunol. 117: 304.
11. CAZENAVE, J. P., S. N. ASSIMEH, R. H. PAINTER, M. A. PACKHAM, and J. F. MUSTARD. 1976. C1q inhibition of the interaction of collagen with human platelets. J. Immunol. 116: 162.
12. ++ in mouse fibroblasts. J. Immunol. 141: 3177.
13. BORDIN, S., and R. C. PAGE. 1988. Role of platelets factors and serum complement in growth of fibroblasts with high affinity C1q complement receptors. In Vitro Cell Dev. Biol. 14: 719.
14. DICKLER, H. B., and H. G. KUNKEL. 1972. Interaction of aggregated γ-globulin with B-lymphocytes. J. Exp. Med. 136: 191.
15. SOBEL, A. T., and V. A. BOKISCH. 1975. In Membrane receptors of lymphocytes. Edited by M. SELIGMAN, F. L. PREUD' HOMME and F. M. KOURILSKY. North Holland Publishing Co., Amsterdam, p. 151.
16. GUPTA, R. C., F. C. MCDUFFIE, G. TAPPEINER, and R. E. JORDON. 1978. Binding of soluble immune complexes to Raji lymphocytes, Role of receptors for complement components C1q and C3-C3b. Immunology. 34: 751.
17. GABAY, Y. H., H. PERLMANN, P. PERLMANN, and A. T. SOBEL. 1979. A rosette assay for determination of C1q receptor bearing cells. Eur. J. Immunol. 9: 797.
18. BORDIN, S., W. P. KOLB, and R. C. PAGE. 1983. C1q receptors on cultured human gingival fibroblasts: analysis of binding properties. J. Immunol. 130: 1871.
19. ARVIEUX, J., A. REBOUL, J. C. BENSA, and M. G. COLOMB. 1984. Characterization of the C1q receptor on a human macrophage cell line, U937. Biochem. J. 218: 547.
20. LAURELL, A.-B., V. JOHNSON, V. MARTENSON, and A. G. SJOHOLM. 1978. Formation of complexes composed of C1r, C1s and C1-inactivator in human serum on activation of C1. Acta. Pathol. Microbiol. Scand. (Sect C). 86: 299.
21. SIM, R. B., G. J. ARLAUD, and M. G. Colomb. 1979. C1 inhibitor dependent dissociation of human complement component C1 bound to immune complexes. Biochem. J. 179: 449.
22. ARLAUD, G. J., A. REBOUL, R. B. SIM, and M. G. COLOMB. 1979. Interaction of C1-inhibitor with C1r and C1s subcomponents of human C1. Biochem. Biophys. Acta. 576: 151.
23. ZICCARDI, R. J., and N. R. COOPER. 1979. Active disassembly of the first complement component, C1 by C1-inactivator. J. Immunol. 123: 788.
24. GHEBREHIWET, B. 1981. C1q inhibitor (C1q-INH): Functional properties and possible relationship to a lymphocyte-membrane associated C1q precipitin. J. Immunol. 126: 1837.
25. GHEBREHIWET, B., and M. HAMBURGER. 1982. Purification and partial characterization of a C1q inhibitor from the membrane of human peripheral lymphocytes. J. Immunol. 129: 157.
26. SILVESTRI, L., J. R. BAKER, L. RODEN, and R. M. STROUD. 1981. The C1q inhibitor in serum is a chondroitin 4-sulphate proteoglycan. J. Biol. Chem. 256: 7383.
27. GHEBREHIWET, B., L. SILVESTRI, and C. MCDEVITT. 1984. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization. J. Exp. Med. 160: 1375.
28. GHEBREHIWET, B. 1987. C1q receptor. Methods in Enzymology. 150: 558.
29. ERDEI, A., and K. B. M. REID. 1988. Characterization of C1q-binding material released from the membranes of Raji and U937 cells by limited proteolysis with trypsin. Biochem. J. 255: 493.
30. ERDEI, A., and K. B. M. REID. 1988. The C1q receptor. Mol. Immunol. 25: 1067.
31. MALHOTRA, R., K. B. M. REID, and R. B. SIM. 1988. Studies on the isolation of C1q-Receptor. Biochem. Soc. Trans. 16: 735.
32. TENNER, A. J., and N. R. COOPER. 1980. Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells. J. Immunol. 125: 1658.
33. MALHOTRA, R., and R. B. SIM. 1989. Chemical and hydrodynamic characterization of the human leukocyte receptor for complement subcomponent C1q. Biochem. J. 262: 625.
34. MALHOTRA, R., A. C. WILLIS, J.-C. JENSENIUS, J. JACKSON, and R. B. SIM. 1993. Structure of Human C1q Receptor (Collectin Receptor): Similarity to a Component ot RoSSA. Immunology 78: 341.
35. DAHA, M. R., L. DUNN, R. VAN DEN BERG, Y. MUIZERTDE-LANGE, A. GERRITSEN, and L. VAN ES. 1993. Isolation and function of a human endothelial cell C1q receptor. Med. Inflamm. 6: 447.
36. ERDEI, A. 1990. C1q receptor on murine cells. J. Immunol. 145: 1754.
37. MCCAULIFFE, D. P., F. A. LUX, T.-S. LIEU, I. SANZ, J. HANKE, M. M. NEWKIRK, L. L. BACHINSKI, Y. ITOH, M. J. SICILIANO, M. REICHLIN, R. D. SONTHEIMER, and J. D. CAPRA. 1990. Molecular cloning, expression, and chromosome 19 localization of a human Ro/SSA autoantigen. J. Clin. Invest. 85: 1379.
38. LU, J., A. C. WILLIS, and R. B. SIM. 1993. A calreticulin-like protein co-purifies with a «60 kD» component of Ro/SSA, but is not recognized by antibodies in Sjogren's syndrome sera. Clin. Exp. Immunol. 94: 429.
39. MEWES, H. W., and K. HEUMANN. 1995. Genome Analysis: Pattern Search in Biological Macromolecules. Combinatorial Pattern Matching; Proceeding; 6th Annual Symposium CPM'95 Espoo, Finland July 1995. Lecture Notes in Computer Science 937: p. 261.
40. BIJWAARD, K., V. J. HEARING, R. SONTHEIMER, T. S. LIEU, W. D. VIEIRA, and D. M. GERSTEN. 1995. Studies on the expression and immunogenicity of the B50 melanoma antigen and its relationship with calreticulin. Melanoma Res. 5: 327.
41. ZHU, Q., P. ZELINKA, T. WHITE, and M. L. TANZER. 1997. Calreticulin-integrin bi-directional signaling complex. Biochem. Biophys. Res. Commun. 232: 354.
42. STUART, G. R., N. J. LYNCH, J. LU, A. GEICK, B. E. MOFFATT, R. B. SIM, and W. J. SCHWAEBLE. 1996. Localisation of the C1q binding site within calreticulin/C1q receptor FEBS Lett. 397: 245.
43. STUART, G. R., N. J. LYNCH, A. J. DAY, W. J. SCHWAEBLE, and R. B. SIM. 1997. The C1q and collectin binding site within C1q receptor (cell-surface calreticulin) Immunopharmacology 38: 73.
44. WHITE, T. K., Q. ZHU, and M. L. TANZER. 1995. Cell surface calreticulin is a putative mannoside lectin which triggers mouse melanoma cell spreading. J. Biol. Chem. 270: 15926.
45. GRAY, A. J., P. W. PARK, T. J. BROEKELMANN, G. J. LAURENT, J. T. REEVES, K. R. STENMARK, and R. P. MECHAM. 1995. The mitogenic effects of the B beta chain of fibrinogen are mediated through cell surface calreticulin. J. Biol. Chem. 270: 26602.
46. EGGLETON, P. B. GHEBREHIWET, K. N. SASTRY, J. P. COBURN, K. S. ZANER, K. B. M. REID, and A. I. TAUBER. 1995. Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R. J. Clin. Invest. 95: 1569.
47. MALHOTRA, R., A. C. WILLIS, A. LOPEZ-BERNAL, S. THIEL, and R. B. SIM. 1994. Mannan-binding protein levels in human amniotic fluid during gestation and its interaction with collectin receptor from amnion cells. Immunology 82: 439.
48. MALHOTRA, R., and R. B. SIM. 1993. Collectin Receptor (C1q receptor) and SP-A mediate binding of pollen grain extracts to lung alveolar type II cells (A549). Molec. Immunol. 30: supp. 1, 30.
49. PLAKIDOU-DYMOCK, S., and J. D. MCGIVAN. 1994. Calreticulin - a stress protein induced in the renal epithelial cell line NBL-1 by amino acid deprivation. Cell Calcium 16: 1.
50. ZHU, J., and M. M. NEWKIRK. 1994. Viral induction of the human autoantigen calreticulin. Clin. Invest. Med. 17: 196.
51. GHEBREHIWET, B., P. D. LU, W. ZHANG, S. A. KEILBAUGH, L. E. A. LEIGH, P. EGGLETON, K. B. M. REID, and E. I. B. PEERSCHKE. 1997. Evidence that the two C1q-binding membrane proteins, gC1q-R and cC1qR, associate to form a complex. J. Immunol. 159: 1429.
52. HOUEN, G., and C. KOCH. 1994. Human placental calreticulin: purification, characterization and association with other proteins. Acta Chem. Scand. 48: 905.
53. MALHOTRA, R., S. THEIL, K. B. M. REID, and R. B. SIM. 1990. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J. Exp. Med. 172: 955.
54. HOLMSKOV, U., S. B. LAURSEN, R. MALHOTRA, H. WIEDEMANN, R. TIMPL, G. R. STUART, I. TORNOE, P. S. MADSEN, K. B. M. REID, and J.-C. JENSENIUS. 1995. Comparative study of the structural and functional properties of a bovine plasma C-type lectin, collectin-43, with other collectins. Biochem. J. 305: 889.
55. MALHOTRA, R., J. HAURUM, S. THIEL, and R. B. SIM. 1992. Interaction of C1q receptor with lung surfactant protein A. Eur. J. Immunol. 22: 1437.
56. MALHOTRA, R., J. HAURUM, S. THIEL, J.-C. JENSENIUS, and R. B. SIM 1993. Pollen grains bind to lung alveolar type II cells (A549) via lung surfactant protein A (SP-A). Biosci. Rep. 13: 79.
57. MALHOTRA, R., S. THIEL, J.-C. JENSENIUS, A. C. WILLIS, and R. B. SIM. 1993. C1q Receptor (Collectin Receptor): Structure and Interaction with Lung Surfactant Protein A. Abs. 8th Int. Cong. Immunol., Budapest, 23-28. Aug., 1992 abstr. 30-10, p. 172. Springer Hungarica, Budapest.
58. MIYAMURA, K., R. MALHOTRA, H. J. HOPPE, K. B. M. REID, P. J. R. PHIZACKERLEY, P. MACPHERSON, and A. L. BERNAL. 1994. Surfactant proteins SP-A and SP-D levels in human amniotic fluid and localisation in the foetal membranes. Biochim. Biophys. Acta. 1210: 303.
59. GEERTSMA, M. F., P. H. NIBBERING, H. P. HAAGSMAN, M. R. DAHA, and R. VAN FURTH. 1994. Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes. Am. J. Physiol. 267: L578.
60. RICE, W. R., G. F. ROSS, F. M. SINGLETON, and J. A. WHITSETT. 1987. Surfactant associated protein inhibits phospholipid secretion from type II cells. J. Appl. Physiol. 63: 692.
61. KUROKI, Y., R. J. MASON, and D. R. VOELKER. 1988. Chemical modification of surfactant protein A alters high affinity binding to rat alveolar type II cells and regulation of phospholipid secretion. J. Biol. Chem. 263: 17596.
62. STRAYER, D. S., S. YANG, and H. H. JERNG. 1993. Surfactant protein A-binding proteins. Characterization and structures. J. Biol. Chem. 268: 18679.
63. MALHOTRA, R., S. B. LAURSEN, A. C. WILLIS, and R. B. SIM. 1993. Localization of the receptor-binding site in the collectin family of proteins. Biochem. J. 293: 15.
64. VAN DEN BERG, R. H., M. FABER KROL, L. A. VAN ES, and M. R. DAHA. 1995. Regulation of the function of the first component of complement by human C1q receptor. Eur. J. Immunol. 25: 2206.
65. PETERSON, J. R., A. ORA, P. N. VAN, and A. HELENIUS. 1995. Transient, lectin-like association of calreticulin with folding intermediates of cellular and viral glycoproteins. Mol. Biol. Cell 6: 1173.
66. KERJASCHKI, D., and M. G. FARQUHAR. 1982. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc. Natl. Acad. Sci. (USA) 79: 5557.
67. RAYCHOWDHURY, R., J. L. NILES, R. T. MCCLUSKEY, and J. A. SMITH. 1989. Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science 244: 1163.
68. SAITO, A., S. PIETROMONACO, A. K.-C. LOO, and M. G. FARQUHAR. 1994. Complete cloning and sequencing of rat gp330/«megalin», a distinctive member of the low density lipoprotein receptor gene family. Proc. Natl. Acad. Sci. (USA) 91: 9725.
69. CHATELET, F., E. BRIANTI, P. RONCO, J. ROLAND, and P. VERROUST. 1986. Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. II. Extrarenal distribution. Am. J. Pathol. 122: 512.
70. KOUNNAS, M. Z., C. C. HAUDENSCHILD, D. K. STRICKLAND, and W. S. ARGRAVES. 1994. Immunological localization of glycoprotein 330, low density lipoprotein receptor-related protein and 39 kDa receptor-associated protein in mouse embryonic tissues. In Vivo 8: 343.
71. ZHENG, G., D. R. BACHINSKY, I. STAMEKOVIC, D. K. STRICKLAND, D. BROWN, G. ANDRES, and R. T. MCCLUSKEY. 1994. Organ distribution in rats of two members of the low density lipoprotein receptor gene family, gp330 and LRP/a2MR, and the receptor-associated protein (RAP). J. Histochem. Cytochem. 42: 531.
72. MOESTRUP, S. K. 1994. The α2-macroglobulin receptor and glycoprotein 330, Two giant receptors mediating endocytosis of multiple ligands. Biochim. Biophys. Acta. 1197: 197.
73. KOUNAS, M. Z., E. B. LOUKINOVA, S. STEFANSSON, J. A. K. HARMONY, B. H. BREWER, D. K. STRICKLAND, and W. S. ARGRAVES. 1995. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem. 270: 13070.
74. ORLANDO, R. A., and M. G. FARQUHAR. 1993. Identification of a cell line that expresses a cell surface and a soluble form of the gp330/receptor-associated protein (RAP) Heymann Nephritis antigenic complex. Proc. Natl. Acad. Sci. (USA), 90: 4082.
75. MOESTRUP, S. K., S. CUI, H. VORUM, C. BREGENGARD, S. E. BJØRN, K. NORRIS, J. GLIEMANN, and E. I. CHRISTENSEN. 1995. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J. Clin. Invest. 96: 1404.
76. MOESTRUP, S. K., E. I. CHRISTENSEN, S. NIELSEN, K. E. JØRGENSEN, S. E. BJØRN, H. RØIGAARD, and J. GLIEMANN. 1994. Binding and endocytosis of proteins mediated by epithelial gp330. Ann. N. Y. Acad. Sci. 737: 124.
77. MOESTRUP, S. K., E. I. CHRISTENSEN, L. SOTTRUP-JENSEN, and J. GLIEMANN. 1987. Binding and receptor mediated endocytosis of pregnancy-zone protein-proteinase complex in rat macrophages. Biochim. Biophys. Acta 930: 297.